JPMORGAN CHASE & CO - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,127 filers reported holding NOVARTIS A G in Q2 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$36,659,385
-6.1%
359,899
-7.0%
0.00%0.0%
Q2 2023$39,056,003
+3.3%
387,037
-5.8%
0.00%
-20.0%
Q1 2023$37,819,508
+95572.9%
411,075
-5.7%
0.01%0.0%
Q4 2022$39,530
-99.9%
435,731
-20.3%
0.01%
-16.7%
Q3 2022$41,559,000
-25.8%
546,745
-17.5%
0.01%
-25.0%
Q2 2022$56,043,000
+192.2%
662,995
+203.3%
0.01%
+300.0%
Q1 2022$19,182,000
-18.3%
218,594
-18.5%
0.00%
-33.3%
Q4 2021$23,474,000
-6.4%
268,370
-12.5%
0.00%0.0%
Q3 2021$25,067,000
-9.1%
306,535
+1.4%
0.00%0.0%
Q2 2021$27,569,000
+12.7%
302,157
+5.6%
0.00%0.0%
Q1 2021$24,460,000
-32.3%
286,150
-25.2%
0.00%
-40.0%
Q4 2020$36,147,000
+16.0%
382,791
+6.9%
0.01%0.0%
Q3 2020$31,158,000
+3.0%
357,964
+3.3%
0.01%
-16.7%
Q2 2020$30,255,000
-14.6%
346,413
-19.4%
0.01%
-25.0%
Q1 2020$35,430,000
-9.3%
429,708
+4.1%
0.01%
+14.3%
Q4 2019$39,070,000
-29.1%
412,610
-35.0%
0.01%
-36.4%
Q3 2019$55,138,000
+44.0%
634,509
+50.6%
0.01%
+57.1%
Q2 2019$38,302,000
-16.2%
421,181
-11.4%
0.01%
-22.2%
Q1 2019$45,726,000
-46.7%
475,606
-52.4%
0.01%
-55.0%
Q4 2018$85,719,000
+77.5%
998,939
+78.2%
0.02%
+122.2%
Q3 2018$48,294,000
-8.8%
560,531
-20.1%
0.01%
-18.2%
Q2 2018$52,970,000
-5.9%
701,223
+0.7%
0.01%
-8.3%
Q1 2018$56,314,000
+1.9%
696,542
+5.9%
0.01%0.0%
Q4 2017$55,246,000
+1.4%
658,005
+2.3%
0.01%0.0%
Q3 2017$54,495,000
+6.6%
643,008
+5.0%
0.01%0.0%
Q2 2017$51,098,000
+28.9%
612,178
+14.7%
0.01%
+33.3%
Q1 2017$39,650,000
-29.8%
533,877
-31.1%
0.01%
-35.7%
Q4 2016$56,472,000
+53.9%
775,287
+66.8%
0.01%
+55.6%
Q3 2016$36,690,000
-67.2%
464,666
-65.8%
0.01%
-67.9%
Q2 2016$111,980,000
+4.0%
1,357,160
-8.7%
0.03%0.0%
Q1 2016$107,649,000
-7.9%
1,486,055
+9.4%
0.03%
-3.4%
Q4 2015$116,827,000
-21.9%
1,357,820
-16.6%
0.03%
-27.5%
Q3 2015$149,588,000
-7.0%
1,627,364
-0.5%
0.04%
+5.3%
Q2 2015$160,882,000
-1.6%
1,635,967
-1.3%
0.04%
+2.7%
Q1 2015$163,474,000
+6.3%
1,657,763
-0.1%
0.04%
+5.7%
Q4 2014$153,777,000
-17.3%
1,659,582
-16.0%
0.04%
-20.5%
Q3 2014$186,021,000
+9.2%
1,976,235
+5.0%
0.04%
+2.3%
Q2 2014$170,384,000
+7.5%
1,882,082
+0.9%
0.04%
-2.3%
Q1 2014$158,510,000
+16.9%
1,864,381
+10.5%
0.04%
+15.8%
Q4 2013$135,616,000
-12.8%
1,687,204
-16.8%
0.04%
-17.4%
Q3 2013$155,485,000
+55.2%
2,026,930
+43.1%
0.05%
+43.8%
Q2 2013$100,180,0001,416,7840.03%
Other shareholders
NOVARTIS A G shareholders Q2 2022
NameSharesValueWeighting ↓
MANAGED ASSET PORTFOLIOS, LLC 237,047$19,165,0006.16%
PRENTISS SMITH & CO INC 127,005$10,268,0005.38%
EXENCIAL WEALTH ADVISORS, LLC 195,903$15,839,0004.71%
Osher Van de Voorde Investment Management 106,315$8,596,0004.37%
BROWN BROTHERS HARRIMAN & CO 8,924,544$721,549,0004.16%
CGOV Asset Management 874,998$70,744,0004.08%
PROFESSIONAL ADVISORY SERVICES INC 218,844$17,694,0003.83%
COMPASS CAPITAL MANAGEMENT, INC 304,931$24,654,0003.69%
First Fiduciary Investment Counsel, Inc. 226,636$18,324,0003.64%
SUMMITRY LLC 456,575$36,914,0003.41%
View complete list of NOVARTIS A G shareholders